New Dual-Target CAR t therapy shows promise for Tough-to-Treat myeloma
NCT ID NCT06235229
First seen Jan 07, 2026 · Last updated May 25, 2026 · Updated 24 times
Summary
This study tests a new treatment called GC012F for people with multiple myeloma, a type of blood cancer, that has returned or stopped responding to at least three prior treatments. GC012F uses a patient's own immune cells, modified to target two proteins (CD19 and BCMA) on cancer cells, aiming to destroy them. The trial has two phases: the first checks safety and the right dose, and the second measures how well the treatment shrinks or controls the cancer. About 110 participants will be enrolled.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Research Site
ACTIVE_NOT_RECRUITINGBeijing, 100024, China
-
Research Site
RECRUITINGBeijing, 102200, China
-
Research Site
RECRUITINGHangzhou, 310003, China
-
Research Site
RECRUITINGJinan, 250117, China
-
Research Site
RECRUITINGShanghai, 200003, China
-
Research Site
RECRUITINGShanghai, 201210, China
-
Research Site
RECRUITINGShenyang, 110134, China
-
Research Site
RECRUITINGWenzhou, 325000, China
-
Research Site
RECRUITINGWuhan, 430030, China
-
Research Site
ACTIVE_NOT_RECRUITINGXi'an, 710004, China
Conditions
Explore the condition pages connected to this study.